Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well bendamustine hydrochloride works in treating patients
with anaplastic glioma or glioblastoma that has come back (recurrent) or growing, spreading
or getting worse (progressive). Drugs used in chemotherapy, such as bendamustine
hydrochloride, work in different ways to stop the growth of tumor cells, either by killing
the cells or by stopping them from dividing.
Phase:
Phase 2
Details
Lead Sponsor:
University of Washington
Collaborators:
National Cancer Institute (NCI) National Comprehensive Cancer Network